» Articles » PMID: 33122355

Physical Traits of Cancer

Overview
Journal Science
Specialty Science
Date 2020 Oct 30
PMID 33122355
Citations 241
Authors
Affiliations
Soon will be listed here.
Abstract

The role of the physical microenvironment in tumor development, progression, metastasis, and treatment is gaining appreciation. The emerging multidisciplinary field of the physical sciences of cancer is now embraced by engineers, physicists, cell biologists, developmental biologists, tumor biologists, and oncologists attempting to understand how physical parameters and processes affect cancer progression and treatment. Discoveries in this field are starting to be translated into new therapeutic strategies for cancer. In this Review, we propose four physical traits of tumors that contribute to tumor progression and treatment resistance: (i) elevated solid stresses (compression and tension), (ii) elevated interstitial fluid pressure, (iii) altered material properties (for example, increased tissue stiffness, which historically has been used to detect cancer by palpation), and (iv) altered physical microarchitecture. After defining these physical traits, we discuss their causes, consequences, and how they complement the biological hallmarks of cancer.

Citing Articles

Mechanical forces in the tumor microenvironment: roles, pathways, and therapeutic approaches.

Zhang Y, Fu Q, Sun W, Yue Q, He P, Niu D J Transl Med. 2025; 23(1):313.

PMID: 40075523 PMC: 11899831. DOI: 10.1186/s12967-025-06306-8.


Focal adhesion in the tumour metastasis: from molecular mechanisms to therapeutic targets.

Liu Z, Zhang X, Ben T, Li M, Jin Y, Wang T Biomark Res. 2025; 13(1):38.

PMID: 40045379 PMC: 11884212. DOI: 10.1186/s40364-025-00745-7.


Regulation of cancer-associated fibroblasts for enhanced cancer immunotherapy using advanced functional nanomedicines: an updated review.

Liao T, Chen X, Qiu F, Zhang X, Wu F, Zhao Z J Nanobiotechnology. 2025; 23(1):166.

PMID: 40038745 PMC: 11877876. DOI: 10.1186/s12951-025-03217-0.


Local soft niches in mechanically heterogeneous primary tumors promote brain metastasis via mechanotransduction-mediated HDAC3 activity.

Tang K, Zheng Y, Hu G, Xin Y, Li K, Zhang C Sci Adv. 2025; 11(9):eadq2881.

PMID: 40009679 PMC: 11864190. DOI: 10.1126/sciadv.adq2881.


Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database.

Vonica R, Morgovan C, Butuca A, Pumnea M, Cipaian R, Frum A Cancers (Basel). 2025; 17(4).

PMID: 40002260 PMC: 11853327. DOI: 10.3390/cancers17040663.


References
1.
Baur A, Stabler A, Bruning R, Bartl R, Krodel A, Reiser M . Diffusion-weighted MR imaging of bone marrow: differentiation of benign versus pathologic compression fractures. Radiology. 1998; 207(2):349-56. DOI: 10.1148/radiology.207.2.9577479. View

2.
Huang S, Chen C, Ingber D . Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension. Mol Biol Cell. 1998; 9(11):3179-93. PMC: 25607. DOI: 10.1091/mbc.9.11.3179. View

3.
Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View

4.
Fukumura D, Kloepper J, Amoozgar Z, Duda D, Jain R . Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol. 2018; 15(5):325-340. PMC: 5921900. DOI: 10.1038/nrclinonc.2018.29. View

5.
Denais C, Gilbert R, Isermann P, McGregor A, Te Lindert M, Weigelin B . Nuclear envelope rupture and repair during cancer cell migration. Science. 2016; 352(6283):353-8. PMC: 4833568. DOI: 10.1126/science.aad7297. View